Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALK-depot SQ Mites in Atopic Dermatitis
NCT00310492Phase 3Completed
- Sponsor
- ALK-Abelló
- Start
- Apr 2006
- Primary completion
- May 2009
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
A Phase 3 trial of ALK-depot SQ mites in atopic dermatitis (AD), sponsored by ALK-Abelló. Started Apr 2006; status: completed.
02
Drugs
ALK-depot SQ mites
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00310492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00310492.